Digitoxin Prolongs Survival of Female Rats With Heart Failure Due to Large Myocardial Infarction

Journal of Cardiac Failure

Volumn 15, Issue 9, 2009, Pages 798-804

  Helber, Izo ^a   Dos Santos, Alexandra A ^a   Antonio, Ednei L ^a   Flumignan, Ronald L G ^a   Bocalini, Danilo S ^a   Piccolo, Camila ^a   Gheorghiade, Mihai ^b   Tucci, Paulo J F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Psychological; survival

Indexed keywords

DIGITOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART PAPILLARY MUSCLE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; WATER CONTENT;

ANIMALS; DIGITOXIN; DISEASE MODELS, ANIMAL; FEMALE; HEART FAILURE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70350571759     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.05.002     Document Type: Article

References (42)

1. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342 (1993) 821-828
2. Køber L., Torp-Pedersen C., Carlsen J.E., Bagger H., Eliasen P., Lyngborg K., et al. A clinical trial of the angiotensin-converting-enzyne inhibitor tandolapril in patients with left ventricular dysfunction after myocardial infarction. Tandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333 (1995) 1670-1676
3. The Digitalis Investigation Group. The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
4. Pfeffer M.A., Braunwald E., Moyé L.A., Basta L., Brown Jr. E.J., Cuddy T.E., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardium infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
5. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 327 (1992) 685-691
6. Adams Jr. K.F., Patterson J.H., Gattis W.A., O'Connor C.M., Lee C.R., Schwartz T.A., et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the Digitalis Investigation Group Trial: a retrospective analysis. J Am Coll Cardiol 46 (2005) 497-504
7. Ahmed A. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. J Gerontol A Biol Sci Med Sci 62 (2007) 323-329
8. Ahmed A., Rich M.W., Love T.E., Lloyd-Jones D.M., Aban I.B., Colucci W.S., et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27 (2006) 178-186
9. Gheorghiade M., van Veldhuisen D.J., and Colucci W.S. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation 113 (2006) 2556-2564
10. Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., and Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289 (2003) 871-878
11. Rich M.W., McSherry F., Williford W.O., Yusuf S., and Digitalis Investigation Group. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol 38 (2001) 806-813
12. Pfeffer M.A., Pfeffer J.M., Steinberg C., and Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72 (1985) 406-412
13. Lapointe N., Blais Jr. C., Adam A., Parker T., Sirois M.G., Gosselin H., et al. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat. J Am Coll Cardiol 39 (2002) 1692-1698
14. Milavetz J.J., Raya T.E., Johnson C.S., Morkin E., and Goldman S. Survival after myocardial infarction in rats: captopril versus losartan. J Am Coll Cardiol 27 (1996) 714-719
15. Marie C., Mossiat C., Gros C., Schwartz J.C., Lecomte J.M., and Bralet J. Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction. Cardiovasc Res 41 (1999) 544-553
16. Mulder P., Richard V., Derumeaux G., Hogie M., Henry J.P., Lallemand F., et al. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96 (1997) 1976-1982
17. Sakai S., Miyauchi T., Kobayashi M., Yamaguchi I., Goto K., and Sugishita Y. Inhibition of myocardial endothelin pathways improves long-term survival in heart failure. Nature 384 (1996) 353-355
18. Levijoki J., Pollesello P., Kaheinen P., and Haikala H. Improved survival with simendan after experimental myocardial infarction in rats. Eur J Pharmacol 419 (2001) 243-248
19. Cury A.F., Bonilha A., Saraiva R., Campos Fo O., Carvalho A.C., de Paola A.A., et al. Myocardial performance index in female rats with myocardial infarction: relationship with ventricular function parameters by Doppler echocardiography. J Am Soc Echocardiogr 18 (2005) 454-460
20. Kanashiro R.M., Nozawa E., Murad N., Gerola L.R., Moisés V.A., and Tucci P.J.F. Myocardial infarction scar plication in the rat: cardiac mechanics in an animal model for surgical procedures. Ann Thorac Surg 73 (2002) 1507-1513
21. Kanashiro R.M., Saraiva R.M., Alberta A., Antonio E.L., Moisés V.A., and Tucci P.J.F. Immediate functional effects of left ventricular reduction: a Doppler echocardiographic study in the rat. J Card Fail 12 (2006) 163-168
22. Bonilha A.M., Saraiva R.M., Kanashiro R.M., Portes L.A., Antonio E.L., and Tucci P.J.F. A routine electrocardiogram cannot not be used to determine the size of myocardial infarction in the rat. Braz J Med Biol Res 38 (2005) 615-619
23. Helber I., Kanashiro R.M., Alarcon Jr. E.A., Antonio E.L., and Tucci P.J.F. A novel inexpensive murine model of oral chronic digitalization. Clin Exp Pharmacol Physiol 31 (2004) 365-366
24. Aldinger E.E. Effects of digitoxin on the development of cardiac hypertrophy in the rat subjected to chronic exercise. Am J Cardiol 25 (1970) 339-343
25. Turto H., and Lindy S. Digitoxin treatment and experimental cardiac hypertrophy in the rat. Cardiovasc Res 7 (1973) 482-489
26. Williams Jr. J.F., Braunwald E., and Studies on digitalis. XI. Effects of digitoxin on the development of cardiac hypertrophy in the rat subjected to aortic constriction. Am J Cardiol 16 (1965) 534-539
27. Peron A.P.O.N., Saraiva R.M., Antonio E.L., Andriolo A., and Tucci P.J.F. Food restriction does not impair myocardial mechanics during the healing period of myocardial infarction in the rat. Nutr Res 25 (2005) 1075-1084
28. Flumignan R.L., Kanashiro R.M., Saraiva R.M., Portes L.A., Antonio E.L., Ishigai M.M.S., et al. Incidence of heart failure in infarcted rats that die spontaneously. Braz J Med Biol Res 39 (2006) 1323-1328
29. Ahmed A., Waagstein F., Pitt B., White M., Zannad F., Young J.B., and Rahimtoola S.H. Effectivesess of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial. Am J Cardiol 103 (2009) 82-87
30. Oxman A., and Guyatt G.H. A consumer's guide to subgroup analyses. Ann Int Med 116 (1992) 78-84
31. Harrison L.I., and Gibaldi M. Pharmacokinetics of digoxin in the rat. Drug Metab Dispos 4 (1976) 88-93
32. 3H-digitoxin in the rat. Biochem Pharmacol 23 (1974) 2567-2575
33. Ahmet I., Krawczyk M., Heller P., Moon C., Lakatta E.G., and Talan M.I. Beneficial effects of chronic pharmacological manipulation of β-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 110 (2004) 1083-1090
34. dos Santos L., Mello A.F.S., Antonio E.L., and Tucci P.J.F. Determination of myocardial infarction size in rats by echocardiography and tetrazolium staining: correlation, agreements, and simplifications. Braz J Med Biol Res 41 (2008) 199-201
35. Allen J.C., and Schwartz A. A possible biochemical explanation for the insensitivity of the rat to cardiac glycosides. J Pharmacol Exp Ther 168 (1969) 42-46
36. Beller G.A., Smith T.W., Abelmann W.H., Haber E., and Hood Jr. W.B. Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 284 (1971) 989-997
37. Adams Jr. K.F., Gheorghiade M., Uretsky B.F., Young J.B., Ahmed S., Tomasko L., et al. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol 30 (1997) 42-48
38. Packer M., Gheorghiade M., Young J.B., Costantini P.J., Adams K.F., Cody R.J., et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 329 (1993) 1-7
39. Uretsky B., Young J.B., Shahidi F.E., Yellen L.G., Harrison M.C., and Jolly M.K. Ramdomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol 22 (1993) 955-962
40. Arnold S.B., Byrd R.C., Meister W., Melmon K., Cheitlin M.D., Bristow J.D., et al. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med 303 (1980) 1443-1448
41. Wasserstrom J.A., and Aistrup G.L. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 289 (2005) H1781-H1793
42. Gheorghiade M., and Ferguson D. Digoxin: a neurohumoral modulator in heart failure?. Circulation 84 (1991) 2181-2186